A public-private partnership to unlock the untargeted kinome. (2013)

First Author: Knapp S
Attributed to:  Innovative targets for circadian drug discovery: REV-ERBalpha and RORalpha funded by EPSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/nchembio.1113

PubMed Identifier: 23238671

Publication URI: http://europepmc.org/abstract/MED/23238671

Type: Journal Article/Review

Volume: 9

Parent Publication: Nature chemical biology

Issue: 1

ISSN: 1552-4450